Oncotarget, a medical journal, was first published in 2010 by Impact Journals. It is a weekly journal that covers all fields of medical science, not only and Oncology but also Cardiology, Neuroscience etc.The Editor in chief is Mikhail Blagosklonny with Andrei V. Gudkov, who are both prominent scientists from Roswell Park Cancer Institute.
Oncotarget is a journal provides access for free to users around the world. Weekly issues of papers are available online from Oncotarget, and they can be read by anyone that is looking to educate themselves about diseases and scientific results. Papers can be used online, or they can be printed in hard copy format. Oncotarget’s mission is to make sure that scientific results are readily available for the public, which enables Oncotarget to enhance research capabilities. Under scientific leadership, Oncotarget has been able assist with solving cures for diseases.
Oncotarget is also available on Dove Press.
Mikhail Blagosklonny is a professor of Oncology at this Institute and well-known for his hypothesis about extending life span using rapamycin (anti-cancer drug). Apart from many entitlements, Andrei V. Gudkov is also known as an author of more than 100 publications.
The main goal that competent authors of this medical journal want to achieve is that the all newest studies become quickly available to all their readers.
Also, it is worth to mention that this journal attempts to overcome the gap between different specialities by gathering researchers from all fields of medicine in one place. The main cause of this concept is to encourage more studies to be done in order to fight deadly diseases and give humanity a hope.